Cargando…

Correction: Challenges in Developing a Validated Biomarker for Angiogenesis Inhibitors: The Motesanib Experience

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374716/
https://www.ncbi.nlm.nih.gov/pubmed/25811784
http://dx.doi.org/10.1371/journal.pone.0121162
_version_ 1782363533524074496
collection PubMed
description
format Online
Article
Text
id pubmed-4374716
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43747162015-04-04 Correction: Challenges in Developing a Validated Biomarker for Angiogenesis Inhibitors: The Motesanib Experience PLoS One Correction Public Library of Science 2015-03-26 /pmc/articles/PMC4374716/ /pubmed/25811784 http://dx.doi.org/10.1371/journal.pone.0121162 Text en © 2015 The PLOS ONE Staff http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Correction
Correction: Challenges in Developing a Validated Biomarker for Angiogenesis Inhibitors: The Motesanib Experience
title Correction: Challenges in Developing a Validated Biomarker for Angiogenesis Inhibitors: The Motesanib Experience
title_full Correction: Challenges in Developing a Validated Biomarker for Angiogenesis Inhibitors: The Motesanib Experience
title_fullStr Correction: Challenges in Developing a Validated Biomarker for Angiogenesis Inhibitors: The Motesanib Experience
title_full_unstemmed Correction: Challenges in Developing a Validated Biomarker for Angiogenesis Inhibitors: The Motesanib Experience
title_short Correction: Challenges in Developing a Validated Biomarker for Angiogenesis Inhibitors: The Motesanib Experience
title_sort correction: challenges in developing a validated biomarker for angiogenesis inhibitors: the motesanib experience
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374716/
https://www.ncbi.nlm.nih.gov/pubmed/25811784
http://dx.doi.org/10.1371/journal.pone.0121162
work_keys_str_mv AT correctionchallengesindevelopingavalidatedbiomarkerforangiogenesisinhibitorsthemotesanibexperience